
The PCA3 test
The number of prostate cancer cases is increasing rapidly.

The number of prostate cancer cases is increasing rapidly.
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.

Cancer may well surpass cardiovascular diseases as the primary case of death in Europe by 2012. To prevent this from happening, cancer therapeutics have to shift in focus from the treatment of symptoms to offering a total cure, despite the complex, multifactorial nature of cancer indications.
Less acute heart attacks in Italy five months after the introduction of a smoking ban in indoor public places.
The University of Pittsburgh Medical Center and GE Healthcare plan to establish over 25 local cancer centres in various countries within the coming decade.
The lower life expectancy of men is mainly due to insufficient uptake of healthcare services and an unhealthy life style Low social status influences men's health far more than women's health Medical care must address men at work, at sports centres, and other gatherings

An innovative scheme using mobile technology to identify patients 'at risk# of developing CVD by effectively establishing smoking status has recently proved a great success for NHS Hammersmith and Fulham.

Lymph nodes play a critical role in the assessment of the spread of cancer, but identifying lymph nodes in surrounding tissue is a difficult task for most image analysis technology. German medical imaging company Definiens now introduced at RSNA 2008 its first computer-aided detection (CAD) application, Lymph Expert, that allows radiologists to identify and analyse lymph nodes volumetrically and…
Germans want a different healthcare system. 93% want individualised services — and they are prepared to pay for them, according to a study relating to the strategies of providers in Germany's healthcare system and their acceptance by the public.
There's little evidence that newer, more expensive drugs work any better than older, cheaper medications. Diabetes, which came 7th in the list of the USA's top mortality causes in 2006, has hit a new high.

Patented Völker Micro-stimulation Systems (MiS) present a complex suspension and are the technical implementation of basal stimulation; they support prophylactic measures, particularly pressure sore prophylaxis, and they are now the standard pressure reduction system used in all Völker beds, the maker reports (Full details: www.voelker.de)
Olwen Glynn Owen reports on MammaPrint, a test that pinpoints the risk of breast cancer recurrence from the primary tumour's genetic make-up. Women with breast cancer tumours under

Patients who have suffered strokes due to stenosis of the carotid artery are at a high risk of suffering further strokes. Many of these second strokes could be avoided if the stenosis was treated in time. This can be done in two ways: Surgical removal of plaque during the endarterectomy, or catheter treatment with a stent being inserted under local anaesthetic, to prevent another stenosis…
There is now new hope for women around the world, with the launch of an early detection test for ovarian cancer, according to HealthLinx Limited. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.

The Anthony Nolan Trust Cord Blood Bank and combined research institute, opened in September at Nottingham Trent University, will store stem cells from the blood of newborn babies' umbilical cords as part of a multi-million pound project that aims to bank 50,000 cord bloods.

The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.

AquilionONE is the first CT scanner capable of imaging whole organ regions up to a width of 16 cm in one rotation and within a split second. Based on the raw volume data, rapid dynamic processes within an entire organ (e. g. heart, pancreas, kidney or brain) may be diagnosed with a time interval of 50 ms, i.e. with a rate of 20 volumes per second.

The safety of medical products, which includes bedding, depends on three pillars: identification of mistakes, updating standards and training.
Lab21 is to expand its portfolio of genetic tests for inherited cardiac syndromes.

During five years of practical experience, Johanna Meyer, Assistant Director of the Nursing Directorate at Gütersloh Municipal Hospital, Germany, has found that a pressure-relieving system made by MTS proved convenient for patients and nurses.

By Hans Peter Hartl, member of the Nursing Directorate at the Department of Gerontopsychiatry, Mainkofen District Hospital, Germany.

At this year's RSNA meeting, Definiens, the number one Enterprise Image Intelligence company, will introduce a new image analysis application that will allow radiologists to analyse lymph nodes volumetrically and compare them over time.

Pressure ulcers are a risk for patients undergoing long surgical procedures. Gel pads, widely used to reduce this risk, are considered to have two major disadvantages: they compromise the patient's thermo regulation by "sucking" warmth from the body and they do not provide sufficient pressure reduction for prominent body parts.

Early suspicions of cancer, either from clinical evidence or medical imaging, are often followed up on biopsy. However, the removal of tissue for histological analysis can be uncomfortable for patients.
Currently, early detection of Prostate Cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample.